Medical specialists from Austria tagged as investigators in clinical trials studying Candidiasis, Chronic Mucocutaneous

Total 3 results

Günter Weiss, Prof. Dr.
Seen in:
- Innsbruck, Medical University Innsbruck
Trials:
- NCT03059992 (Principal Investigator)
Conditions:
Robert Krause, PD Dr. med.
Seen in:
- Graz, Medical University of Graz Department of Internal Medicine, Department of Pulmology, Section for Infectious Disease and Tropical Medicine
Trials:
- NCT03059992 (Principal Investigator)
Conditions:
Stephan Eschertzhuber, Prof. Dr.
Seen in:
- Innsbruck, Medical University Innsbruck
Trials:
- NCT03059992 (Sub-Investigator)
Conditions:

Clinical Trials on Candidiasis, Chronic Mucocutaneous

National Institute of Allergy and Infectious Diseases...

Completed

Rituximab for Anti-cytokine Autoantibody-Associated Diseases

Pulmonary Alveolar Proteinosis (PAP) | Severe Mucocutaneous Candidiasis

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Natural History of Individuals With Immune System Problems That Lead to Fungal Infections

Invasive Aspergillosis | Chronic Mucocutaneous Candidiasis | CARD9 | APECED

United States
Scynexis, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)

Coccidioidomycosis | Invasive Pulmonary Aspergillosis | Allergic Bronchopulmonary Aspergillosis | Histoplasmosis | Chronic Pulmonary Aspergillosis | Blastomycosis | Invasive Candidiasis | Recurrent Vulvovaginal Candidiasis | Mucocutaneous Candidiasis | Other Emerging Fungi

United States, Spain, United Kingdom, Austria, Pakistan, South Africa, Germany, Netherlands
Matinas BioPharma Nanotechnologies, Inc.

Completed

CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis (CAMB)

Candidiasis, Chronic Mucocutaneous

United States
Duke University
National Institute of Allergy and Infectious Diseases (NIAID); Children's Hospital...

Completed

PEACE: Pediatric Antifungal Comparative Effectiveness (PEACE)

Pediatric Invasive Candidiasis

United States, Colombia, Canada, India, Saudi Arabia, Greece, Italy, Spain
Centre Hospitalier Universitaire Dijon

Completed

Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis. (EMPIRICAND)

Invasive Candidiasis; Treatment With Echinocandin

France
Robert Krause, MD

Completed

Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?

Invasive Candidiasis | Pulmonary Candidiasis

Austria
Astellas Pharma Inc

Completed

Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Candidemia | Invasive Candidiasis | Esophageal Candidiasis | Oropharyngeal Candidiasis

United States, South Africa
Astellas Pharma Inc

Completed

Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Candidemia | Invasive Candidiasis | Esophageal Candidiasis | Oropharyngeal Candidiasis

United States
Yung Shin Pharm. Ind. Co., Ltd.

Completed

Evaluate Bioequivalence of Micafungin (50mg/Vial)

Invasive Candidiasis

Taiwan

Medical specialists from Austria tagged as investigators in clinical trials studying Candidiasis, Chronic Mucocutaneous

Clinical Trials on Candidiasis, Chronic Mucocutaneous

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations